Physician profile
Katherine A Morrison
NPI 1508229188
$11,793.31
in general payments reported to CMS, 2019-2025
39 companies · $2,020 in 2025
The $2,020 reported for 2025 was more than what 93% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,702 · 2020: $2,047 · 2021: $1,934 · 2022: $637 · 2023: $2,057 · 2024: $397 · 2025: $2,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,658 · Food and Beverage: $1,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,658.11 |
| Food and Beverage | $1,815.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,792.98 | 2019-2021 | |
| Arthrex, INC. | $1,686.35 | 2020 | |
| Treace Medical Concepts, INC. | $1,567.44 | 2022-2023 | |
| Mimedx Group, INC. | $1,504.87 | 2025 | |
| Paragon 28, INC. | $1,280.82 | 2019-2022 | |
| Stryker Corporation | $680.61 | 2019-2025 | Actishield, Hoffmann, Prostep Mica |
| Biotissue Holdings INC. | $352.50 | 2025 | |
| Smith+Nephew, INC. | $296.10 | 2019-2025 | Grafix Pl, Grafix |
| Integra Lifesciences Corporation | $257.86 | 2020-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $195.89 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Horizon Therapeutics Plc | $121.35 | 2019-2021 | |
| Abbvie INC. | $101.38 | 2021-2023 | |
| Osteomed LLC | $97.29 | 2021 | |
| Depuy Synthes Sales INC. | $93.54 | 2022-2024 | Motoband, Minibunion, N/A |
| Organogenesis INC. | $77.57 | 2021-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $71.65 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $48.99 | 2024 | Onpattro |
| Tactile Systems Technology INC | $46.19 | 2020-2023 | Flexitouch Plus, Entre Plus |
| Merck Sharp & Dohme LLC | $45.68 | 2024-2025 | Verquvo |
| Kci USA, INC. | $35.31 | 2019-2021 | |
| Nevro Corp. | $31.80 | 2021 | |
| Convatec INC. | $31.71 | 2023 | |
| Paratek Pharmaceuticals, INC. | $30.85 | 2021 | |
| Axogen | $29.56 | 2021 | |
| Averitas Pharma INC. | $29.17 | 2023 | Qutenza |
| Kiniksa Pharmaceuticals International, Plc | $29.04 | 2024 | Arcalyst |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.35 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $23.71 | 2024 | Xarelto |
| Grt US Holding, INC. | $23.12 | 2022 | |
| Medtronic, INC. | $22.27 | 2022 | |
| Davol INC. | $22.05 | 2025 | Arista |
| Medartis INC. | $21.21 | 2021 | |
| Amgen INC. | $20.52 | 2025 | Krystexxa |
| Solventum Corporation | $19.41 | 2025 | Activ.A.C., 3m Cavilon |
| Acell, INC. | $17.67 | 2020 | |
| Reprise Biomedical, INC. | $17.15 | 2021 | |
| Pfizer INC. | $15.92 | 2021 | |
| Checkpoint Surgical, INC | $15.11 | 2020 | |
| Ermi LLC | $14.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.